Author | Setting | AIDS population | Sub-analyses | VAS1) | TTO | SG | EQ-5D index |
---|---|---|---|---|---|---|---|
Hughes | South Africa | WHO stages 3 or 4 | General community | 0.80 | Â | Â | Â |
(2004) | (Cape Town) | or CD4<200 | Awaiting ART | 0.60 | Â | Â | Â |
Jelsma | South Africa | WHO stages 3 or 4 | General community | 0.80 | Â | Â | Â |
(2005) | (Cape Town) | or CD4<200 | Awaiting ART | 0.62 | Â | Â | Â |
 |  |  | ART (1 month) | 0.70 |  |  |  |
 |  |  | ART (3 months) | 0.71 |  |  |  |
 |  |  | ART (6 months) | 0.74 |  |  |  |
 |  |  | ART (12 months) | 0.76 |  |  |  |
Louwagie | South Africa | WHO stage 4 or | ART (own health) | 0.66 | Â | Â | 0.80 |
(2007) | (Free State) | CD4<200 | Awaiting ART | 0.62 | Â | Â | 0.69 |
Lara | Uganda | WHO stages | Own health (ART and non ART) | 0.50 and 0.55 | Â | Â | Â |
(2008) | (Entebbe) | 2, 3 or 4 | WHO stage 2 (ART and non ART) | 0.59 and 0.63 | 0.75 and 0.78 | 0.50 and 0.51 | Â |
 |  |  | WHO stage 3 (ART and non ART) | 0.39 and 0.39 | 0.49 and 0.52 | 0.34 and 0.39 |  |
 |  |  | WHO stage 4 (ART and non ART) | 0.17 and 0.15 | 0.20 and 0.27 | 0.19 and 0.19 |  |
 |  |  | Own health reassessed (ART and non ART) | 0.78 and 0.66 |  |  |  |